Focused Palliative Care Intervention in Advanced Heart Failure
Heart Failure, Quality of Life
About this trial
This is an interventional supportive care trial for Heart Failure focused on measuring Heart Failure, Palliative Care
Eligibility Criteria
Inclusion Criteria
- Symptomatic Heart Failure (NYHA II-IV)
Hospitalized or recently for acute decompensation with at least one of the following high-risk features
- Prior hospitalization for Heart Failure (HF) within 1 year
- Age > 80 years
- Chronic Kidney Disease (estimated Glomerular Filtration Rate (eGFR) < 45 mL/min/m2)
- Systolic Blood Pressure < 100 mm Hg
- Serum sodium < 130 meq/L
- Cardiogenic Shock (Cardiac Index < 2.0)
- Serious Non-Cardiovascular Illness (e.g. advanced stage cancer, Chronic Obstructive Pulmonary Disease (COPD) , or the like.
- Ability to Provide Informed Consent
- Permission of attending physician
Exclusion Criteria
- Anticipated major cardiac surgery, including Ventricular Assist Device (VAD) or transplant, within 3 months of enrollment
- Already enrolled in hospice or receiving outpatient palliative care
Sites / Locations
- Brigham and Women's Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Control
Verbal Information and Discussion
Participant will receive usual care for Heart Failure patients, which include standard written material on Advanced Care planning and supportive cardiology/palliative care consult if ordered by attending.
Participants will participate in a guided goals of care conversation and the support of a Palliative Care Social Worker who is working closely with the patients' primary cardiology team. Social worker has ongoing clinical review of participants with a Palliative Care physician who will provide a full medical consult if appropriate.